Lesch and colleagues found that CAR-T cells that strongly express CXCR6 (its ligand is highly expressed by human and mouse PDAC cells and tumor-infiltrating immune cells) enhance the recognition and efficacy against tumor cells [44]. The gene discussed is CXCR6; the disease is neoplasm.